Gerald Downey

Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective

Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective

Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells

Macrophages in immunoregulation and therapeutics

Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver

Plant based insect repellent and insecticide treated bed nets to protect against malaria in areas of early evening biting vectors: double blind randomised placebo controlled clinical trial in the Bolivian Amazon

Consort 2010 statement: extension to cluster randomised trials

Clinical Pharmacokinetic and Pharmacodynamic Profile of the HIV Integrase Inhibitor Elvitegravir

Malaria

A Review of Cancer Immunotherapy Toxicity II: Adoptive Cellular Therapies, Kinase Inhibitors, Monoclonal Antibodies, and Oncolytic Viruses

The methodological quality of cluster randomised controlled trials for managing tropical parasitic disease: a review of trials published from 1998 to 2007

The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth

Global Status of DDT and Its Alternatives for Use in Vector Control to Prevent Disease

Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas

Global status of DDT and its alternatives for use in vector control to prevent disease

The Next Decade of Immune Checkpoint Therapy

Hepatitis C Virus Neuroinvasion: Identification of Infected Cells

Chemical Pesticides and Human Health: The Urgent Need for a New Concept in Agriculture

Combining fosamprenavir with lopinavir/ritonavir substantially reduces amprenavir and lopinavir exposure: ACTG protocol A5143 results

DEET mosquito repellent provides personal protection against malaria: a household randomized trial in an Afghan refugee camp in Pakistan

Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III–IV melanoma

DEET mosquito repellent sold through social marketing provides personal protection against malaria in an area of all‐night mosquito biting and partial coverage of insecticide‐treated nets: a case–control study of effectiveness

Phase IIIb safety results from an expanded-access protocol of talimogene laherparepvec for patients with unresected, stage IIIB–IVM1c melanoma